Thu, 29 Oct 2026
06:20:56 am
Rudransh Sangwan
Published at: October 29, 2026, 3:08 AM
Synopsis
Northwest Pipe Q3 results show EPS of $1.86, beating estimates by 12.73%, while sales rose 18.75% year-on-year to $179.39 million.

Northwest Pipe Company (NASDAQ: NWPX) reported earnings per share (EPS) of $1.86 for the third quarter, beating analyst expectations of $1.65 by 12.73%.
Quarterly sales increased 18.75% year-on-year to $179.39 million, exceeding the consensus estimate of $150.80 million. Earnings and revenue both surpassed analyst forecasts.
| Metric | Current Quarter | Year-Ago Quarter | YoY Change | Analyst Estimate |
|---|---|---|---|---|
| EPS | $1.86 | $1.38 | +34.78% | $1.65 |
| Sales | $179.39 million | $151.07 million | +18.75% | $150.80 million |
Northwest Pipe’s EPS rose 34.78% compared with the same quarter last year, faster than its 18.75% sales growth. This indicates that earnings increased at a faster rate than revenue, although detailed margin figures were not provided.
The company exceeded expectations on both earnings and sales, with quarterly EPS coming in above forecasts and revenue surpassing estimates by approximately 18.96%.
This article is for informational purposes only and is not investment advice.
Northwest Pipe Company reported Q3 earnings per share of $1.86 and sales of $179.39 million. Both figures exceeded analyst expectations of $1.65 EPS and $150.80 million in sales.
Northwest Pipe's EPS of $1.86 beat the $1.65 consensus estimate by approximately 12.73%. This means earnings per share were about $0.21 higher than expected.
Northwest Pipe's quarterly sales increased 18.75% year-on-year to $179.39 million, compared with $151.07 million in the year-ago quarter.
Northwest Pipe exceeded analyst forecasts for both EPS and sales. Earnings grew 34.78% year-on-year, while sales increased 18.75%, indicating faster growth in earnings than revenue.
Northwest Pipe's EPS increased to $1.86 from $1.38 a year earlier, representing year-on-year growth of approximately 34.78%.
Northwest Pipe reported sales of $179.39 million against analyst expectations of $150.80 million. Revenue exceeded the estimate by $28.59 million, or approximately 18.96%.
Not necessarily. EPS grew faster than sales, but the figures provided do not establish the exact change in operating or net profit margins. Detailed cost and profitability data would be needed to confirm margin improvement.
Investors may monitor future sales growth, profit margins, order demand, operating costs and management's outlook. The sustainability of earnings growth matters alongside whether the company continues to outperform analyst expectations.

Financial journalist specializing in market analysis, stock research, and investment trends. Dedicated to providing accurate, timely insights for informed decision-making.
Credentials: Experienced financial journalist with expertise in equity markets and economic analysis
The information provided in this article is for educational and informational purposes only and should not be construed as financial, investment, or legal advice. welomoney does not provide personalized investment recommendations.
For detailed terms and conditions, please read our Disclaimer and Terms of Service.

Piramal Pharma shares surged 16.04% after Q2 FY27 profit reached ₹5 crore and revenue rose 28%. Choice Institutional Equities set a ₹250 target.

Jubilant Ingrevia shares fell 6.13% to ₹593.60 despite East Bridge Capital Master Fund I buying 9.21 lakh shares worth ₹55.46 crore, acquiring a 0.

Titagarh Rail Systems received an additional ₹1,716.90 crore Ministry of Railways order, raising the amended contract value to ₹10,404.10 crore.

Everest Group Q3 2026 results show net operating EPS of $7.62, below estimates, as net premiums earned fell 18.

Force Motors Q2 FY27 results show revenue rising 40.5% to ₹2,924.5 crore, while standalone net profit falls 16.6% to ₹291.